Screening for AL Amyloidosis in Smoldering Multiple Myeloma

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

February 27, 2029

Study Completion Date

February 27, 2029

Conditions
Smoldering Multiple Myeloma
Trial Locations (13)

10032

RECRUITING

Columbia University Irving Medical Center, New York

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

23219

RECRUITING

VCU Medical Center, Richmond

27705

RECRUITING

UNC Lineberger Comprehensive Cancer Center, Durham

28204

RECRUITING

Atrium Health Levine Cancer Institute, Charlotte

33331

RECRUITING

Cleveland Clinic Florida, Weston Hospital, Weston

35233

RECRUITING

University of Alabama Hospital, Birmingham

43210

RECRUITING

The Ohio State University Comprehensive Cancer Center, Columbus

75390

NOT_YET_RECRUITING

UT Southwestern, Harold C. Simmons Comprehensive Cancer Center, Dallas

84112

RECRUITING

University of Utah, Huntsman Cancer Hospital, Salt Lake City

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

94143

RECRUITING

University of California, San Francisco, San Francisco

02111

RECRUITING

Tufts Medical Center, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Tufts Medical Center

OTHER